New medications and treatments for ovarian cancer are constantly being developed. These must be shown to be safe and effective before doctors can prescribe them to patients. Through clinical trials, researchers test the effects of new drugs on a group of volunteers with ovarian cancer. Following a strict protocol and using carefully controlled conditions, researchers evaluate the investigational drugs under development and measure the ability of the new drug to treat ovarian cancer, its safety, and any possible side effects.
Some patients with ovarian cancer are reluctant to take part in clinical trials for fear of getting no treatment at all. This is not always the case. Patients who participate in clinical trials may receive the most effective therapy available for their condition -- or they may receive treatments that are being evaluated for future use. The drugs being tested may be even more effective than the current ovarian cancer treatment, or they may be found to be ineffective or too toxic. The specifics about a particular clinical trial should be discussed with your doctor.
Although ovarian cancer rarely produces symptoms in its earliest stages, eventual warning signs may include:
Vague digestive disturbances, such as mild indigestion, bloating, feeling of fullness, or loss of appetite, gas
Diarrhea, constipation, or a frequent need to urinate
Pain or swelling in the abdomen, or pain in the lower back or pelvic pressure
Vaginal bleeding between menstrual periods or after menopause
Symptoms associated with advanced ovarian cancer include...
This web site, developed by the nonprofit Coalition of Cancer Cooperative Groups, is an unbiased cancer clinical trial matching and navigation service enabling patients to search for cancer trials based on disease and location.